Please note: This is a Single Viewer eCast registration for one participant for this eCast for both the live and on-demand version of this eCast. If you are interested in presenting this program to a group, please see the “eCast Registration Form– Group Viewing” form on the eCast program page.
...
Please note: This is a Single Viewer eCast registration for one participant for this eCast for both the live and on-demand version of this eCast. If you are interested in presenting this program to a group, please see the “eCast Registration Form– Group Viewing” form on the eCast program page.
Access instructions for the live eCast will be provided via email approximately 2-3 business days prior to the live program date. Access instructions for the on-demand version of this program will be provided via email approximately 7-10 business days after the live program has occurred and the on-demand version is available. If registering after the on-demand version is available, access is granted via the AABB Education Website at https://education.aabb.org.
Program Description: With new infectious diseases, severe weather, civil unrests, material and supply shortages, cyber threats, we are frequently faced with new extreme scenarios to which we have to be prepared. The recent COVID-19 pandemic presented our global community with new challenges and forced us to be more resilient and creative than ever before. With cellular therapies becoming an increasingly integral part of the healthcare community providing a state-of-the-art lifesaving patient care has its unique challenges. These include safe transport of perishable products with demanding storage requirements, decreased revenues, shortage of unique materials, limited access to back-up facilities, product transportation, and complex communication and documentation requirements. All of which require strict adherence to regulatory and accreditation requirements. This program will review the current state of a global pandemic threat and describe the specific challenges faced by cell therapy collection and processing facilities and clinical transplant programs. We will discuss what changes are needed to current disaster plans including reassessment of our risk mitigation strategies. We also will review the need to improve organizational, national, and global coordination efforts and creation of support networks.